11 stories found
The Democratic Republic of Congo faces a severe Ebola outbreak, with over 2,500 deaths and a rapid spread, prompting international appeals for aid and vaccine distribution. Miners in the region continue to risk exposure due to economic hardship, complicating containment efforts.
The Democratic Republic of Congo has received over 16,000 doses of the Ebola vaccine to combat an unprecedented and rapidly spreading outbreak. The arrival of the vaccines is a critical step in addressing the escalating health crisis in the country.
The Democratic Republic of Congo has received 70,000 doses of the Ervebo vaccine as the Bundibugyo Ebola outbreak continues to spread, aiming to curb the surge in infections.
The Ervebo vaccine has proven safe and effective against the common Zaire strain of the Ebola virus, with early data suggesting it may also protect against the rarer Bundibugyo strain, potentially leading to public availability in DR Congo.
The Democratic Republic of Congo has received its first shipment of Ebola vaccines as the current outbreak continues to grow exponentially. This delivery aims to bolster efforts to control the spread of the deadly virus.
The Ebola epidemic in the Democratic Republic of Congo is spreading exponentially, with the death toll surpassing 2,500 people. The UN has warned that funds are running out in the fight against the disease, while the WHO has raised the risk level to 'very high'.
The Democratic Republic of Congo is set to receive 70,000 doses of the Ervebo vaccine to combat a surge in Ebola infections. This delivery aims to bolster the country's efforts against the escalating health crisis.
The number of Ebola cases in the Democratic Republic of Congo has surpassed 4,000, marking the country's largest outbreak on record. The World Health Organization and other health bodies are urging stronger community response and vaccine trials as conflict hampers efforts to contain the rapidly spreading virus.
DW News. . The Democratic Republic of Congo has received more than 16,000 doses of the Ervebo Ebola vaccine as authorities intensify efforts to contain the country's largest-ever Ebola outbreak.
The Democratic Republic of Congo has received 70,000 doses of the Ervebo vaccine to combat the rapidly spreading Ebola outbreak. However, the World Health Organization noted that these doses are not approved for the specific Bundibugyo strain currently prevalent in the region.
WHO vaccine experts have recommended a full-scale human trial of the only existing approved Ebola vaccine, Ervebo, to assess its cross-protection against a deadly strain spreading in the Democratic Republic of Congo.